Ryzumvi
Payments companies reported to CMS as associated with Ryzumvi. "Associated with" is CMS's wording: it links a payment to a product without saying the money was spent on it.
By year
Payments reported as associated with Ryzumvi, per program year, as reported to CMS.
Who makes it
Specialties most often involved
Where the associated payments went, by the receiving clinician's specialty.
Clinicians most associated with Ryzumvi
These are the largest totals companies reported as associated with Ryzumvi. They are typically speaking or consulting arrangements, which companies must report by law; appearing here is not evidence of anything improper.
| Clinician | Location | Specialty | Associated payments (2023-2025) |
|---|---|---|---|
| Jay Pepose | Chesterfield, MO | $420,452.96 | |
| Peter Kollbaum | Bloomington, IN | Optometrist | $48,000.00 |
| John Rumpakis | Lake Oswego, OR | Optometrist | $11,301.50 |
| Alice Epitropoulos | Columbus, OH | Ophthalmology | $9,947.77 |
| Joseph Thimons | Fairfield, CT | Optometrist | $3,573.90 |
| Yun-Sen Chu | Bloomington, MN | Ophthalmology | $2,850.00 |
| Ranjan Malhotra | Saint Louis, MO | Ophthalmology | $2,700.00 |
| Mitchell Moffitt | Twin Falls, ID | Pediatrics | $2,637.00 |
| Carl Regillo | Plymouth Meeting, PA | Ophthalmology | $1,650.00 |
| Mile Brujic | Bowling Green, OH | Optometrist | $1,359.21 |
Prescribed Ryzumvi?
See what its makers reported for your doctor. Two steps, private, no account.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.